Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $22,144 - $46,749
-12,950 Reduced 41.39%
18,337 $34,000
Q3 2022

Nov 21, 2022

SELL
$1.9 - $8.63 $46,033 - $209,087
-24,228 Reduced 43.64%
31,287 $77,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $57,769 - $244,369
27,122 Added 95.52%
55,515 $135,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $178,308 - $442,646
28,393 New
28,393 $226,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Seaport Global Advisors, LLC Portfolio

Follow Seaport Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaport Global Advisors, LLC with notifications on news.